ELAB
Price
$4.36
Change
-$0.19 (-4.18%)
Updated
Apr 3, 01:20 PM (EDT)
Capitalization
2.63M
EPIX
Price
$1.60
Change
+$0.03 (+1.90%)
Updated
Apr 3, 03:21 PM (EDT)
Capitalization
70.13M
40 days until earnings call
Ad is loading...

ELAB vs EPIX

Header iconELAB vs EPIX Comparison
Open Charts ELAB vs EPIXBanner chart's image
PMGC Holdings
Price$4.36
Change-$0.19 (-4.18%)
Volume$200
Capitalization2.63M
ESSA Pharma
Price$1.60
Change+$0.03 (+1.90%)
Volume$350
Capitalization70.13M
ELAB vs EPIX Comparison Chart
Loading...
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAB vs. EPIX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAB is a Hold and EPIX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ELAB: $4.55 vs. EPIX: $1.58)
Brand notoriety: ELAB and EPIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELAB: 24% vs. EPIX: 42%
Market capitalization -- ELAB: $2.63M vs. EPIX: $70.13M
ELAB [@Biotechnology] is valued at $2.63M. EPIX’s [@Biotechnology] market capitalization is $70.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAB’s FA Score shows that 1 FA rating(s) are green whileEPIX’s FA Score has 1 green FA rating(s).

  • ELAB’s FA Score: 1 green, 4 red.
  • EPIX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ELAB and EPIX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAB’s TA Score shows that 5 TA indicator(s) are bullish while EPIX’s TA Score has 5 bullish TA indicator(s).

  • ELAB’s TA Score: 5 bullish, 3 bearish.
  • EPIX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ELAB and EPIX are a good buy in the short-term.

Price Growth

ELAB (@Biotechnology) experienced а -10.78% price change this week, while EPIX (@Biotechnology) price change was +3.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.30%. For the same industry, the average monthly price growth was -10.41%, and the average quarterly price growth was -14.40%.

Reported Earning Dates

EPIX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EPIX($70.1M) has a higher market cap than ELAB($2.63M). EPIX YTD gains are higher at: -11.732 vs. ELAB (-71.616). ELAB has higher annual earnings (EBITDA): -4.75M vs. EPIX (-30.57M). EPIX has more cash in the bank: 120M vs. ELAB (6.43M). ELAB has less debt than EPIX: ELAB (103K) vs EPIX (305K). ELAB has higher revenues than EPIX: ELAB (2.45M) vs EPIX (0).
ELABEPIXELAB / EPIX
Capitalization2.63M70.1M4%
EBITDA-4.75M-30.57M16%
Gain YTD-71.616-11.732610%
P/E RatioN/AN/A-
Revenue2.45M0-
Total Cash6.43M120M5%
Total Debt103K305K34%
FUNDAMENTALS RATINGS
EPIX: Fundamental Ratings
EPIX
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELABEPIX
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JELD6.090.25
+4.28%
JELD-WEN Holding
SWBI9.500.17
+1.82%
Smith & Wesson Brands
NFLX935.527.14
+0.77%
Netflix
FUTU103.470.10
+0.10%
Futu Holdings Limited
TOPS6.46-0.04
-0.62%
TOP Ships

ELAB and

Correlation & Price change

A.I.dvisor tells us that ELAB and EPIX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELAB and EPIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAB
1D Price
Change %
ELAB100%
+5.08%
EPIX - ELAB
31%
Poorly correlated
+1.28%
LXRX - ELAB
25%
Poorly correlated
+8.40%
EDSA - ELAB
22%
Poorly correlated
+5.60%
ALLK - ELAB
21%
Poorly correlated
+48.06%
REGN - ELAB
20%
Poorly correlated
+1.39%
More